Application 219935
- Type
- NDA
- Sponsor
- SAGENT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FAMOTIDINE | FAMOTIDINE | SOLUTION;INTRAVENOUS | 20MG/5ML (4MG/ML) | Yes | Yes |
| 002 | FAMOTIDINE | FAMOTIDINE | SOLUTION;INTRAVENOUS | 40MG/10ML (4MG/ML) | Yes | Yes |
| 003 | FAMOTIDINE | FAMOTIDINE | SOLUTION;INTRAVENOUS | 200MG/50ML (4MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N219935-001 | FAMOTIDINE | FAMOTIDINE | 20MG/5ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | |
| N219935-002 | FAMOTIDINE | FAMOTIDINE | 40MG/10ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | |
| N219935-003 | FAMOTIDINE | FAMOTIDINE | 200MG/50ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N219935-001 | FAMOTIDINE | 20MG/5ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219935-002 | FAMOTIDINE | 40MG/10ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N219935-003 | FAMOTIDINE | 200MG/50ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219935-001 | FAMOTIDINE | 20MG/5ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219935-002 | FAMOTIDINE | 40MG/10ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N219935-003 | FAMOTIDINE | 200MG/50ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219935-001 | FAMOTIDINE | 20MG/5ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219935-002 | FAMOTIDINE | 40MG/10ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N219935-003 | FAMOTIDINE | 200MG/50ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219935-001 | FAMOTIDINE | 20MG/5ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219935-002 | FAMOTIDINE | 40MG/10ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N219935-003 | FAMOTIDINE | 200MG/50ML (4MG/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2025-07-16 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Famotidine | FAMOTIDINE | Sagent Pharmaceuticals | 9710995d-b518-40ce-bc2b-8b5dcf002c31 | 2026-06-06 | Warnings, Adverse reactions | 219935 NDA219935 |